Danaher Disappoints with Q3:23 Sales and Profit Decline

Danaher Disappoints with Q3:23 Sales and Profit Decline

Danaher Corp. (NYSE: DHR), a well-known player in the medical device market, recently unveiled its third-quarter financial results on October 24. With a global presence, Danaher specializes in the design, manufacture and distribution of professional, medical, industrial and commercial products and services. The latest earnings report painted a somber picture for Danaher, as the company grappled with a decline in both sales and profits compared to the previous year. This underwhelming performance came as the pharma and biotech sectors experienced a broader loss of momentum in critical markets. “Pharma and biotech took a modest step down, and that was particularly the case in the U.S. In... Read More »

Laboratories, MRI & Dialysis Deals Dropped in 2016

Deal volume settled down in 2016, following a very busy 2015 in the Laboratories, MRI & Dialysis sector. The 41 deals recorded represent a 21% decline compared with the 52 announced in 2015. Laboratories have had to adapt as hospitals and health systems have merged or closed in recent years. Some labs have evolved to offer coordinated diagnostics: offering tests that give on-the-spot diagnoses, handling bills and lab data from several sources and providers as an aid to accountable care organizations, and focusing on the patient experience to ensure repeat business. At the same time, deal value surged in 2016, up 166% year-over-year to $11.6 billion. Two multi-billion-dollar deals... Read More »